Who is the CEO of CGON? | Glauxie AI

Q: Who is the CEO of CGON?

CG Oncology, Inc. Common stock (CGON) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Arthur Kuan. CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their... Employees: 85,000.

Q: What does CGON company do?

Learn what CGON does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling CGON?

Track recent insider buys and sells for CGON with transaction details, amounts, and trends.

Q: What sector is CGON in?

Find CGON sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of CGON?

🦉

CG Oncology, Inc. Common stock (CGON)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOArthur Kuan

CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients...

Key Executives

Name	Title
Ambaw Bellete	President & Chief Operating Officer
Amy Steele	Vice President of Finance & Administration
Arthur Kuan	Chairman & Chief Executive Officer
Bing Kung	Vice President of Corporate Development
James DeTore	Chief Financial Officer
Joshua F. Patterson	General Counsel, Chief Compliance Officer & Secretary

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

CGON Profile Financials

What does CGON company do? Are insiders buying or selling CGON? What sector is CGON in?